You Don’t Know What You’ve Got Till It’s Gone
In this op/ed in The New York Post, AIMS president Brian Lee Crowley explains the real reason why brand-name drugs cost less in Canada. In reply to an ad campaign by the American Association of Retired Persons (AARP) urging Congress to legalize the importation of prescription drugs from Canada, Crowley explains the reason isn't simply price controls. And he tells Americans to be very careful what they wish for.